As of June 30, 2026, Chemiesynth (Vapi) Ltd. carries a market capitalization of 205.34M, placing it among publicly traded companies globally. Its enterprise value stands at 205.34M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 205.34M |
| Enterprise Value | 205.34M |
As of June 30, 2026, Chemiesynth (Vapi) Ltd. has 3.07M shares outstanding.
| Shares Outstanding | 3.07M |
These figures are as of June 30, 2026.
| PS Ratio | 0.95 |
As of June 30, 2026, Chemiesynth (Vapi) Ltd. trades at an EV/EBITDA multiple of 17.09 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.95 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 205.34M versus a market cap of 205.34M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.95 |
| EV / EBITDA | 17.09 |
These figures are as of June 30, 2026.
| Interest Coverage | 1.18 |
Over the twelve months ended June 30, 2026, Chemiesynth (Vapi) Ltd. recorded an income tax benefit of -589,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -11.76M and -11.17M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -589,000.00 |
As of the close on October 21, 2026, Chemiesynth (Vapi) Ltd.'s stock has gained approximately 234.73% over the past 52 weeks.
| 52-Week Price Change | 234.73% |
Over the twelve months ended June 30, 2026, Chemiesynth (Vapi) Ltd. generated 216.58M in revenue and converted that into -11.17M in net income, yielding earnings per share of -3.64. EBITDA reached 12.02M, while operating income came in at -1.88M.
| Revenue | 216.58M |
| Gross Profit | 156.98M |
| Operating Income | -1.88M |
| Pretax Income | -11.76M |
| Net Income | -11.17M |
| EBITDA | 12.02M |
| EBIT | -1.88M |
| Earnings Per Share (EPS) | -3.64 |
Over the twelve months ended June 30, 2026, Chemiesynth (Vapi) Ltd. posted a gross margin of 72.48, reflecting its pricing power and cost economics. The operating margin of -0.87 and net profit margin of -5.16 provide insight into operational efficiency.
| Gross Margin | 72.48 |
| Operating Margin | -0.87 |
| Pretax Margin | -5.43 |
| Profit Margin | -5.16 |
| EBITDA Margin | 5.55 |
Already premium?